Health ❯ Metabolic Disorders

Obesity

Type 2 Diabetes Diabetes Fatty Liver Disease Dental Health Pharmacological Advances Epigenetics Diet-induced Obesity Hormonal Imbalance Therapeutics Gestational Diabetes Adipogenesis Cardiovascular Disease

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

The pact reflects a broader pivot to lower-cost oral alternatives to injectable GLP-1 treatments.

Prolynx Raises $70 Million to Advance Ultra-Long-Acting Obesity Drugs

Review Spotlights Senotherapeutics as Emerging Approach for Metabolic Disease

PNAS Study Identifies CHP1 as Master Regulator of Lipid Droplet Growth

Single CRISPR Treatment Lets Mice Produce Weight-Loss Drug for Over Six Months